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Abstract
Background: Dexamethasone (DEX), a synthetic glucocorticoid, is commonly used to prevent or lessen the morbidity of
chronic lung disease in preterm infants. However, evidence is now increasing that this clinical practice negatively affects
somatic growth and may result in long-lasting neurodevelopmental deficits. We therefore hypothesized that supporting
normal somatic growth may overcome the lasting adverse effects of neonatal DEX treatment on hippocampal function.
Methodology/Principal Findings: To test this hypothesis, we developed a rat model using a schedule of tapering doses of
DEX similar to that used in premature infants and examined whether the lasting influence of neonatal DEX treatment on
hippocampal synaptic plasticity and memory performance are correlated with the deficits in somatic growth. We confirmed
that neonatal DEX treatment switched the direction of synaptic plasticity in hippocampal CA1 region, favoring low-
frequency stimulation- and group I metabotropic glutamate receptor agonist (S)-3,5,-dihydroxyphenylglycine-induced long-
term depression (LTD), and opposing the induction of long-term potentiation (LTP) by high-frequency stimulation in the
adolescent period. The effects of DEX on LTP and LTD were correlated with an increase in the autophosphorylation of Ca
2+/
calmodulin-dependent protein kinase II at threonine-286 and a decrease in the protein phosphatase 1 expression. Neonatal
DEX treatment resulted in a disruption of memory retention subjected to object recognition task and passive avoidance
learning. The adverse effects of neonatal DEX treatment on hippocampal synaptic plasticity and memory performance of
the animals from litters culled to 4 pups were significantly less than those for the 8-pup litters. However, there was no
significant difference in maternal care between groups.
Conclusion/Significance: Our results demonstrate that growth retardation plays a crucial role in DEX-induced long-lasting
influence of hippocampal function. Our findings suggest that therapeutic strategies designed to support normal
development and somatic growth may exert beneficial effects to reduce lasting adverse effects following neonatal DEX
treatment.
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Introduction
The synthetic glucocorticoid dexamethasone (DEX) is com-
monly used to prevent or treat chronic lung disease in preterm
infants with respiratory distress syndrome [1,2,3]. The treatment
regimen typically consists of high doses of DEX for several weeks,
notably during a critical period for the development of brain
function. Therefore, growing concern has arisen for the long-term
safety of this clinical practice on the brain development of the
child. There is now increasing evidence that early-life DEX
exposure negatively affects somatic growth and is associated with
an increased risk of adverse neurodevelopmental outcome.
Although long-term follow-up studies are scarce as yet, a recent
study reported that school-age children who were treated with
DEX as preterm infants have impaired neuromotor skills and
cognitive performance [4]. Barrington’s review of 8 randomized
controlled studies enrolling 679 infants also showed a significant
risk for neurodevelopmental abnormalities and cerebral palsy after
early DEX treatment [5]. These findings raise important questions
concerning the mechanisms underlying these neurodevelopmental
abnormalities and whether these alterations are long-lasting.
Given controlled prospective and mechanistic study with humans
is limited, a convenient way to answer these questions is using an
appropriate animal model that simulates the DEX treatment used
clinically during neonatal life.
To date, a number of clinically relevant animal models have
been developed to investigate the lasting neurological outcome of
neonatal DEX treatment. It is estimated that in terms of brain
growth rate, the brain of a rat pup around birth is comparable
with that of a preterm human infant brain, born during 26–32
weeks gestation [6,7]. Given these developmental correlations, a 3-
day tapering course of DEX treatment in the neonatal rat pup on
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effects of neonatal DEX treatment on the developing brain
[8,9,10]. With the use of this model, we and others have recently
demonstrated that DEX exposure in the neonatal rat pups may
lead to alterations in synaptic plasticity and memory performance
in the adult hippocampus [8,9]. Although these results highlight
the risk for long-lasting behavioral and physiological alterations
associated with neonatal DEX treatment, little is known about the
mechanisms behind these abnormalities. As a result, there is at
present no comprehensive strategy to combat adverse effects of
neonatal DEX treatment on neurodevelopment.
Clinical studies have demonstrated that preterm infants
receiving DEX therapy have reduced growth rate, decreased
weight gain, and smaller head circumferences [11,12]. There is
also ample evidence in animal studies that neonatal DEX
treatment causes long-lasting adverse effects on gross somatic
growth and brain weight [9,13,14]. The causal link between the
decreased somatic growth and the occurrence of abnormal
neurological outcomes induced by neonatal DEX treatment has
not yet been established. Interestingly, we have recently demon-
strated that although DEX exposure in the neonatal rat pups alters
hippocampal synaptic plasticity and the formation of contextual
fear memory in adolescence, these effects do not persist into
adulthood [9]. This motivated us to investigate whether supporting
normal somatic growth may overcome the adverse effects of
neonatal DEX treatment on hippocampal function in later life.
Because the litter size in which rodent pups are reared is known to
affect their preweaning somatic growth [15,16], we employ culling
(a reduction in the litter size) advantage for measuring the role of
growth retardation in lasting effects of neonatal DEX treatment on
hippocampal synaptic plasticity and function.
Results
Effect of culling on somatic growth retardation induced
by neonatal DEX treatment
To study the role of growth retardation in lasting adverse effects
of neonatal DEX treatment on hippocampal synaptic plasticity and
function, we took advantage of culling to increase body weight gain
[15,16]. We first examined the influence of litter size on postnatal
somatic growth of rat pups. In agreement with previous
observations [8,9,13,14], neonatal DEX-treated pups gained weight
at a slower rate than saline (SAL)-treated rats for up to 6 weeks after
treatment was discontinued (Figure 1). Compared to SAL-treated
rat pups from litters culled to 8 (Group A), the rat pups from litters
culled to 4 (Group B) showed a faster growth rate on postnatal (P)8-
P28 (p,0.05). By P29-P42, there were no significant differences in
body weight between SAL-treated Group A and Group B. In
addition, post hoc analysis revealed that DEX-treated rat pups in
Group B weighed significantly higherthan thoseinDEX-treatedrat
pups in Group A on P17-P42 (p,0.05), but by P1-P16 there was no
body weight difference between groups. These results suggest that
culling can partially, but significantly, overcome the growth
retardation induced by neonatal DEX treatment.
In contrast to the adverse effect on somatic growth, histopath-
ological evaluation using cresyl violet staining showed that
neonatal DEX treatment does not significantly affect the total
number of neurons in the stratum pyramidale of the hippocampal
CA1 region compared with SAL-treated rats at 5 weeks of age
(p.0.05, unpaired Student’s t-test) (Figure S1).
Effect of culling on maternal care
The quality of postpartum maternal care may modulate
hippocampal development and function [17]. To determine whether
culling may influence maternal care of pups, we measured the
amount of time spent in contact between dam and pups over the first
10 days postpartum. Maternal contact was defined as any behavior
that involved in physical contact or close proximity to pups and
almost invariably implied nursing and/or licking/grooming [18,19].
As shown in Figure 2A, the percentage of time spent in the maternal
contact during the observation period did not differ between neonatal
SAL- and DEX-treated rat pups in both Group A and Group B.
Further statistical analysis of data revealed that the frequency of
maternal licking/grooming was not different between groups across
all days of the observation period (Figure 2B). In addition, as reported
previously [20], no indications were found for altered maternal care
received by neonatal SAL- and DEX-treated rat pups.
Effect of culling on neonatal DEX treatment-induced
alteration in glutamatergic synaptic transmission
An increased glutamatergic synaptic transmission at the
Schaffer/collateral-CA1 synapses following neonatal DEX treat-
Figure 1. Effect of neonatal DEX treatment on body weight. (A)
DEX-treated rats had significantly lower body weights compared with
SAL-treated rats at most ages during the preweaning period (P1-P21)
for Group A (8 pups/litter) and Group B (4 pups/litter). (B) DEX-treated
rats weighted significantly less than SAL-treated rats during the
postweaning period (P22-P42) for Group A and Group B. Data represent
the mean 6 SEM (n=10 for each group).
doi:10.1371/journal.pone.0012806.g001
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experiment, we examined the influence of culling on the effect
of neonatal DEX treatment on basal glutamatergic synaptic
transmission by comparing stimulus-response relationships for
extracellular field excitatory postsynaptic potential (fEPSP). As
compared with slices from SAL-treated 5-week-old rats, neonatal
DEX-treated rats in Group A showed a significant leftward shift in
the stimulus-response curve of the fEPSP (p,0.05) (Figure 3A).
However, no significant differences in stimulus-response relation-
ships were found between SAL- and DEX-treated rats in Group B
(p.0.05) (Figure 3B). These findings are in agreement with
previous report [9] and support the view that neonatal DEX
treatment enhances basal glutamatergic synaptic transmission in
the hippocampal CA1 region in later life and such effect is
effectively overcome by culling.
We next tested whether the effect of neonatal DEX treatment
on basal synaptic transmission reported above was attributable to
an increase in presynaptic probability of neurotransmitter release.
To address this question, we examined the paired-pulse facilitation
(PPF), a short-lasting form of presynaptic plasticity in which the
second of two closely spaced stimuli elicits enhanced transmitter
release [21]. As shown in Figure 3C and 3D, pairs of presynaptic
fiber stimulation pulses delivered at interpulse intervals of 20, 40,
60, 80, 150, and 200 ms evoked nearly identical amounts of PPF
ratio in slices from DEX- and SAL-treated rats from both Group
A and Group B. These results suggest that the presynaptic function
at the Schaffer/collateral-CA1 synapses remains normal following
neonatal DEX treatment.
Effect of culling on neonatal DEX treatment-induced
alterations in the induction of long-term potentiation
and long-term depression
Previous studies from our laboratory and those of others have
demonstrated that tapering neonatal DEX treatment may alter the
inducibility of hippocampal CA1 long-term potentiation (LTP)
and long-term depression (LTD) in later life [8,9,10]. To
determine the influence of culling on the effects of neonatal
DEX treatment on long-term synaptic plasticity, we analyzed the
induction of LTP and LTD in the CA1 region of the
hippocampus. In slices from 5-week-old SAL-treated rats,
conditioning high-frequency stimulation (HFS) induced a robust
LTP of fEPSPs (50 min after HFS: Group A, 165.169.1% of
baseline, n=12, p,0.05; Group B, 158.668.5% of baseline,
n=10, p,0.05) (Figures 4A, 4C and 4E). There was a striking
difference in the effect of neonatal DEX treatment on LTP
induction between Group A and Group B. Although neonatal
DEX treatment resulted in an impaired LTP induction in slices
from both Group A (122.564.8% of baseline, n=12) and Group
B rats (138.264.6% of baseline, n=15), the impairment of LTP in
slices from Group B rats was significantly less than those from
Group A rats (p,0.05) (Figure 4E). On the contrary, LTD was
induced by applying low-frequency stimulation (LFS) at 1 Hz for
15 min. As shown in Figures 4B and 4D, slices from 5-week-old
DEX-treated rats showed a reliable LFS-induced LTD (50 min
after the end of LFS: Group A, 74.564.2% of baseline, n=11,
p,0.05; Group B, 86.364.5% of baseline, n=18, p,0.05)
compared with slices from age-matched SAL-treated rats (Group
A, 95.464.8% of baseline, n=11; Group B, 96.566.5% of
baseline, n=10). However, the magnitude of LFS-induced LTD in
neonatal DEX-treated rats was significant reduced in slices from
Group B rats compared with those from Group A rats (p,0.05)
(Figure 4F).
At the Schaffer collateral-CA1 synapses, N-methyl-D-aspartate
(NMDA) receptor-dependent LTD coexists with another form of
LTD mediated by activation of group I metabotropic glutamate
receptors (mGluRs) [22]. This mGluR-dependent LTD can be
elicited by bath application of a group I mGluR agonist (S)-3,5,-
dihydroxyphenylglycine (DHPG) over a short period of time
[23,24,25]. Moreover, these two forms of LTD differ with respect
to their underlying mechanisms [26,27]. We then examined
whether the induction of mGluR-dependent LTD was also altered
by neonatal DEX treatment. In slices from 5-week-old SAL-
treated rats, a brief bath application of DHPG (50 mM) for 5 min
elicited a robust LTD (50 min after washout of DHPG: Group A,
54.464.2% of baseline, n=7, p,0.05; Group B, 58.563.5% of
baseline, n=8, p,0.05) (Figures 5A and 5B). Slices from neonatal
DEX-treated rats displayed an enhanced DHPG-induction LTD
(Group A, 31.363.6% of baseline, n=9; Group B, 49.463.6% of
baseline, n=12) compared with slices from SAL-treated rats.
Likewise, the magnitude of DHPG-induced LTD in neonatal
DEX-treated rats was significant reduced in slices from Group B
rats compared with slices from Group A rats (p,0.05) (Figure 5C).
Figure 2. Effect of litter size on maternal care over the first 10
days postpartum. (A) Percentage of time spent in maternal contact
(the total of all behavioral categories involving contact between dam
and pups including licking/grooming, arched-back nursing, flat-back
nursing, passive nursing) across days in neonatal SAL- and DEX-treated
rat pups for Group A and Group B. (B) Percentage of time spent in
maternal licking/grooming behavior across days in neonatal SAL- and
DEX-treated rat pups for Group A and B. Data represent the mean 6
SEM (n=8 for each group).
doi:10.1371/journal.pone.0012806.g002
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LTP but enhances LTD induction in the hippocampal CA1 region
in later life and such effects are effectively overcome by culling.
In previous studies [9,10], we established that the effects of
neonatal DEX treatment on LTP and LTD induction are
correlated with an increase in the autophosphorylation of a
isoform of Ca
2+/calmodulin-dependent protein kinase II (CaM-
KIIa) at threonine-286 in hippocampal postsynaptic density (PSD)
fraction and a decrease in the protein phosphatase 1 (PP1)
expression in hippocampal CA1 homogenate. Accordingly, we
examined the influence of culling on the effects of neonatal DEX
treatment on the basal levels of phosphorylated CaMKIIa at
threonine-286 and PP1 protein expression. As previous shown [9],
in Group A, neonatal DEX treatment led to an increase in
CaMKIIa autophosphorylation (174.165.8%, n=12, p,0.05)
(Figure 6A) and a decrease in PP1 expression (78.264.6%, n=12,
p,0.05) compared with neonatal SAL treatment (Figure 6B).
However, no significant effects of neonatal DEX treatment on the
levels of CaMKIIa autophosphorylation (110.265.2%, n=12,
p.0.05) and PP1 protein (96.164.1%, n=12, p.0.05) were seen
in rats from Group B compared with SAL-treated rats (Figures 6A
and 6B).
Many cellular stimuli that elevate intracellular free Ca
2+ may
increase CaMKIIa autophosphorylation, including an increase in
intrinsic neuronal excitability. To test this possibility, we measured
hippocampal CA1 neuronal excitability by quantifying the
number of action potentials fired in response to postsynaptic
depolarizing current injection (0.2 nA, 500 ms). As shown in
Figure S2, there was no significant difference between slices from
SAL- and DEX-treated rats in the firing responses to depolarizing
current injections. We also found no significant changes on
membrane potential, action potential threshold, or kinetics in
hippocampal CA1 pyramidal neurons in slice from DEX-treated
rats compared with SAL-treated rats at 5 weeks old.
Figure 3. Culling reduces the effects of neonatal DEX treatment on basal synaptic transmission in hippocampal CA1 region. (A)
Stimulus-response curve of fEPSP versus stimulus intensity at the Schaffer collateral-CA1 synapses of hippocampal slices from 5-week-old rats of
Group A that received neonatal SAL (n=5) or DEX treatment (n=5). Inset shows overlaid traces (each an average of 3 responses) evoked in a slice
from a SAL- (left set of traces) and DEX-treated (right set of traces) rats. (B) Stimulus-response curve of fEPSP versus stimulus intensity at the Schaffer
collateral-CA1 synapses of hippocampal slices from 5-week-old rats of Group B that received neonatal SAL (n=5) or DEX treatment (n=5). (C)
Comparison of PPF ratio in slices from 5-week-old rats of Group A that received neonatal SAL (n=5) or DEX treatment (n=5). The plot summarizes
facilitation of the second fEPSP slope relative to the first one as a function of the interpulse intervals of 20–200 ms. The inset shows example PPF
(average of 3 responses) obtained with interpulse interval of 40 ms in slices from SAL- and DEX-treated rats. (D) Comparison of PPF ratio in slices from
5-week-old rats of Group B that received neonatal SAL (n=5) or DEX treatment (n=5). Data represent the mean 6 SEM.
doi:10.1371/journal.pone.0012806.g003
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for generalized enhancement of neuronal excitability and
parvalbumin-expressing interneurons have been reported to play
a key role in coordinating of neuronal network excitability of the
hippocampus [28], we then examined whether neonatal DEX
treatment affects parvalbumin-expressing interneurons. Morpho-
logical studies have revealed that at least two types of
parvalbumin-expressing interneurons in the hippocampus: large,
multiple-polar round shaped, axon-somal basket cells and smaller,
spindle shaped, axo-axonic chandelier cells [28]. Quantitative
analysis indicated that there was no significant effect of neonatal
DEX treatment on the total number of multiple-polar round
shaped and spindle shaped parvalbumin-expressing interneurons
in the stratum origin and pyramidale of the hippocampal CA1
region in rats from both Group A and Group B (Figure S3). In
addition, culling resulted in no significant differences in the total
number of parvalbumin-expressing interneurons.
To further assess whether neonatal DEX treatment leads to a
change in the GABAA receptor-mediated inhibition, we compared
inhibitory postsynaptic currents (IPSCs) recorded in hippocampal
CA1 pyramidal neurons in slices from SAL- and DEX-treated
rats. Monosynaptic IPSCs were evoked while holding neurons in
voltage-clamp at 220 mV in the presence of 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; 20 mM) and D-(-)-2-amino-
5-phosphonopentanoic acid (D-APV; 50 mM). Figure S4 depicts
the relationship between stimulus intensity and IPSC amplitude.
Figure 4. Culling reduces the effects of neonatal DEX treatment on LTP and LTD in hippocampal CA1 region. (A) Summary graphs of
LTP induced with a HFS in slices from 5-week-old rats of Group A that received neonatal SAL or DEX treatment. (B) Summary graphs of LTD induced
with a prolonged LFS in slices from 5-week-old rats of Group A that received neonatal SAL or DEX treatment. (C) Summary graphs of LTP induced with
a HFS in slices from 5-week-old rats of Group B that received neonatal SAL or DEX treatment. (D) Summary graphs of LTD induced with a prolonged
LFS in slices from 5-week-old rats of Group B that received neonatal SAL or DEX treatment. (E) Summary bar graphs depicting levels of potentiation
measured 50 min after HFS in slices from neonatal SAL- or DEX-treated rats for Group A and Group B. (F) Summary bar graphs depicting levels of
depression measured 50 min after LFS in slices from neonatal SAL- or DEX-treated rats for Group A and Group B. The total number of animals
examined is indicated by n in parenthesis. Representative traces of fEPSPs were taken at the time indicated by number. Horizontal bars denote the
period of delivery of LFS. The dashed lines show the level of baseline. Data represent the mean 6 SEM. *p,0.05 compared with SAL-treated rats.
doi:10.1371/journal.pone.0012806.g004
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found between SAL- and DEX-treated rats of both Group A and
Group B (Figure S4A and S4B). We also examined the effect of
neonatal DEX treatment on miniature IPSC (mIPSC) properties
in hippocampal CA1 neurons. Neonatal DEX treatment did not
Figure 5. Culling reduces the facilitatory effect of neonatal DEX
treatment on DHPG-induced LTD in hippocampal CA1 region.
(A) Summary graphs of LTD induced with a brief application of mGluR
agonist DHPG (50 mM) for 10 min in slices from 5-week-old rats of
Group A that received neonatal SAL or DEX treatment. (B) Summary
graphs of LTD induced with a brief application of DHPG (50 mM) for
10 min in slices from 5-week-old rats of Group B that received neonatal
SAL or DEX treatment. (C) Summary bar graphs depicting levels of
depression measured 50 min after washout of DHPG in slices from
neonatal SAL- or DEX-treated rats for Group A and Group B. The total
number of animals examined is indicated by n in parenthesis.
Representative traces of fEPSPs were taken at the time indicated by
number. Horizontal bars denote the period of delivery of DHPG. The
dashed lines show the level of baseline. Data represent the mean 6
SEM. *p,0.05 compared with SAL-treated rats.
doi:10.1371/journal.pone.0012806.g005
Figure 6. Culling reduces the effects of neonatal DEX treatment
on CaMKIIa phosphorylation at threonine-286 and PP1 ex-
pression in hippocampal CA1 region. (A) Representative Western
blot and summary bar graph depicting levels of CaMKIIa phosphory-
lation at threonine-286 in hippocampal CA1 PSD purified from 5-week-
old rats neonatally treated with SAL or DEX for Group A and Group B.
(B) Representative Western blot and summary bar graph depicting
levels of PP1 in hippocampal CA1 homogenates from 5-week-old rats
neonatally treated with SAL or DEX for Group A and Group B. The total
number of animals examined is indicated by n in parenthesis. Data
represent the mean 6 SEM. *p,0.05 compared with SAL-treated rats.
doi:10.1371/journal.pone.0012806.g006
DEX Alters Synaptic Function
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compared with SAL-treated rats in both Group A and Group B
(Figure S4C and S4D).
Effect of culling on neonatal DEX treatment-induced
impairment of hippocampus-dependent associative
learning and memory
We have previously found that neonatal DEX treatment may
impair hippocampus-dependent learning and memory task [9,10].
We next investigated whether culling could also reduce learning
and memory deficits of neonatal DEX-treated rats measured in
the object recognition and passive avoidance tests. At 5 weeks of
age, neonatal DEX-treated rats in Group A showed significant
decline in the recognition of a novel object [F(1,15)=8.5, p=0.01],
observed as a decreased time of exploring or sniffing the novel
object (Figure 7A). However, neonatal DEX-treated rats in Group
B performed significantly better on the object recognition task
than did neonatal DEX-treated rats in Group A [F(1,15)=4.3,
p=0.04]. Notably, the object recognition index did not signifi-
cantly differ between neonatal SAL- and DEX-treated rats in
Group B [F(1,12)=0.4, p=0.56] (Figure 7B). The total distance
traveled did not differ between groups during the memory
retention tests (Figures 7C and 7D).
In one-trial passive avoidance test, no significant between-group
differences in performance were noted during the training session.
But on the day of testing, performance of 5-week-old neonatal
DEX-treated rats in Group A have significantly shorter step-
through latencies to enter the dark compartment [34.8610.7
seconds, n=18; F(1,29)=6.5, p=0.02] than SAL-treated rats
(91.5622.1 seconds, n=12) (Figure 8A). In contrast, there was no
significant difference in memory retention performance between
neonatal SAL- (87.4618.4 seconds, n=14) and DEX-treated rats
[52.6614.6 seconds, n=14; F(1,27)=2.2, p=0.15] in Group B at 5
week old (Figure 8B). These results clearly show that hippocam-
pus-dependent associative learning and memory is impaired by
neonatal DEX treatment and culling can effectively overcome
these memory impairments.
Discussion
The present study investigated the role of growth retardation in
lasting detrimental effects of neonatal DEX treatment on
hippocampal synaptic plasticity and memory performance. Our
results confirmed that neonatal DEX treatment retarded somatic
growth and impaired LTP but enhanced LTD in hippocampal
CA1 region in later life [8,9,10]. In addition, neonatal DEX-
treated rats showed impaired memory performance in the tasks of
object recognition and passive avoidance conditioning. Increasing
preweaning milk intake by culling significantly stimulated somatic
growth and overcame the adverse effects of neonatal DEX
treatment on hippocampal synaptic plasticity and memory
performance. Improved performance in hippocampus-associated
learning and memory tasks and synaptic plasticity by culling was
not associated with any detectable alteration in postpartum
maternal care or total number of pyramidal neurons or
parvalbumin-expressing interneurons in the CA1 region of the
hippocampus.
Normal somatic growth is the result of the proper interactions of
genetic, nutritional, metabolic, and endocrine factors. Both clinical
and experimental studies have shown that early-life DEX exposure
has a lasting adverse effect on gross somatic growth
[9,11,12,13,14]. Consistent with these earlier findings, our results
indicated that DEX-treated rats weighted significantly less than
those of SAL-treated rats up to 6 weeks after cessation of the
treatment (Figure 1). Although the cause of the lasting growth
retardation observed in DEX-treated rats remain unclear, this
adverse effect may be linked, at least in part, to the inadequate
nutritional intake during the postnatal period [3] or the rise in
tissue catabolism or protein breakdown after DEX treatment
[14,29]. Because we and others did not find the difference in
maternal care between SAL- and DEX-treated groups [20], the
somatic growth deficits observed in DEX-treated rats cannot be
explained by the deleterious effects of child abuse or neglect.
Although several previous studies have reported that brain weights
are decreased after neonatal DEX treatment [13,14,30] and that
neuronal progenitor cells in the dentate gyrus are subjects to DEX-
induced apoptosis [31], we found no significant effect of neonatal
DEX treatment on the total number of pyramidal neurons or
parvalbumin-expressing interneurons in hippocampal CA1 region
(Figures S1 and S3). These findings are not consistent with those of
Kreider et al [32], who reported that neonatal DEX treatment
elicited small but relatively consistent deficits in the number and
size of neural cells in the hippocampus that persisted into
adulthood. The reason for this discrepancy is unclear, but it could
be attributed to the use of different regimens and doses of DEX
(daily doses of 0.05, 0.2 or 0.8 mg/kg versus tapering doses of
0.5 mg/kg on P1, 0.3 mg/kg on P2, and 0.1 mg/kg on P3 in our
study), resulting in activation of different cellular processes that
vary in their mode of action. Another important difference is that
Kreider et al [32] measured cell number and size by the DNA
concentration and content while we used immunohistochemical
staining method in our experiments. Much more work, however, is
necessary to fully understand this issue.
We and others have previously reported that neonatal DEX
treatment alters hippocampal synaptic plasticity and function in
later life [8,9,10]. Our data also identified a close link between
somatic growth impairment and long-lasting deficits in hippocam-
pal synaptic function in neonatal DEX-treated rats [9]. At 8-week-
old age, at which no significant differences in body weight were
observed between neonatal SAL- and DEX-treated rats, DEX-
treated rats exhibited normal hippocampal synaptic plasticity and
contextual fear memory performance compared with SAL-treated
rats [9]. In the present study, we have, in addition, extended these
findings by demonstrating that culling can support somatic growth
and effectively overcome the adverse effects of neonatal DEX
treatment on hippocampal LTP and LTD, as well as hippocam-
pus-dependent associative learning and memory performance.
Furthermore, we show that the heightened basal synaptic
transmission observed in slices from neonatal DEX-treated rats
was also overcome by culling. In rodents, litter size affects pup
postnatal growth and development [15,16]. The culling paradigm
is one of the few known experimental processes that can accelerate
somatic growth in preweaning period of rat pups. The question
then arises as to how litter size affects the postnatal growth of rat
pups. The correlation between the body weight gain of pups and
the litter size is generally believed to be due to the availability of
maternal milk [33,34]. That is pups from culled litters may be
heavier due to greater milk availability. Furthermore, we found
that maternal contact did not become higher as litter size culled to
4 (Figure 2), suggesting that the influence of litter size on the
postnatal growth of rat pups was not associated with alterations in
postpartum maternal care. This is in agreement with Champagne
et al [19] who reported that litter size has little effect on interaction
between mother and pups. However, we could not exclude the
possibility that factors other than increased milk availability may
also be involved in the beneficial effects of culling.
Consistent with previous findings [8,9,10], we found that,
compared with SAL-treated rats, DEX-treated rats exhibited an
DEX Alters Synaptic Function
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hippocampal PSD fraction. It has been shown that threonine-286
phosphorylation is sufficient to convert the CaMKII to the high
affinity form [35]. Thus, it is possible that the greater level of
autophosphorylated CaMKIIa binds a greater amount of Ca
2+/
calmodulin, which in turn leads to systematic shift in favor of LTD
at all submaximal levels of Ca
2+ influx triggered by LFS. Indeed, it
has been shown that transgenic mice overexpressing a mutated
form of CaMKIIa with autonomous activity display a downward
shift of the frequency response curve, favoring LTD over LTP
induction in the hippocampal CA1 region [36]. Since the increase
in CaMKIIa autophosphorylation observed in DEX-treated rats is
correlated with a reduction of PP1 level, it is likely that neonatal
DEX treatment may provide a unidentified mechanism for
decreased PP1 production, which renders the CaMKIIa persis-
tently hyperphosphorylated [9]. This notion is strengthened by our
observation that culling reduced the lasting effects of neonatal
DEX treatment on CaMKIIa and PP1 (Figure 6) and improved
deficits in LTP and LTD. In addition, we observed that neonatal
DEX treatment also led to a significant increase in the magnitude
of DHPG-induced LTD and such effect was significantly reduced
by litter culling (Figure 5). This finding is consistent with previous
report showing that stress, through activation of glucocorticoid
receptors by corticosterone, facilitates the induction of DHPG-
induced LTD in hippocampal CA1 region [37]. However, it is not
clear how neonatal DEX treatment exerted its long-lasting effects
on mGluR-dependent LTD. Interestingly, a previous study [38]
found that 17b-estradiol may facilitate the induction of DHPG-
LTD in the hippocampal CA1 region through an enhancement of
CaMKII activity. It is therefore possible that the lasting facilitatory
effect of neonatal DEX treatment on DHPG-induced LTD is
associated with a maintained increase in CaMKII activity.
Additional studies are required to test this possibility.
With respect to long-lasting neurological outcome measures of
neonatal DEX treatment, we have previously reported that this
DEX regimen treatment may lead to an impairment of
hippocampus-dependent contextual fear memory performance
[9]. Besides affecting memory retention for one-trial passive
Figure 7. Culling rescues object recognition memory deficits in neonatal DEX rats. (A) Performance in the object recognition task is
expressed as a discrimination index corresponding to the percentage of increase above the time spent exploring the familiar object during the test
session. Summary bar graphs depicting levels of discrimination index from 5-week-old rats neonatally treated with SAL or DEX for Group A. (B)
Summary bar graphs depicting levels of discrimination index from 5-week-old rats neonatally treated with SAL or DEX for Group B. (C) Summary bar
graphs depicting total distance traveled during a 5 min trial of 5-week-old rats neonatally treated with SAL or DEX for Group A. (D) Summary bar
graphs depicting total distance traveled during a 5 min trial of 5-week-old rats neonatally treated with SAL or DEX for Group B. The total number of
animals examined is indicated by n in parenthesis. Data represent the mean 6 SEM. *p,0.05 compared with SAL-treated rats.
doi:10.1371/journal.pone.0012806.g007
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neonatal DEX treatment also elicited deficits in novel object
recognition test (Figure 7). In rodents, the novel object recognition
test has become the currently accepted standard for assessing
recognition memory. Although novel object recognition probably
involves a wide range of brain areas and neuronal processes, there
is agreement that the hippocampus is critically important for
normal recognition memory performance [39,40]. The present
results provide further support for this view by demonstrating that
neonatal DEX treatment caused deficits in hippocampal synaptic
plasticity and novel object recognition performance. Importantly,
our data show that, in keeping with its effect on synaptic plasticity,
culling effectively overcame the neonatal DEX treatment-induced
impaired performance in hippocampus-dependent associative
learning tasks.
In conclusion, our work reveals a critical role of growth
retardation in lasting effects of neonatal DEX treatment on
hippocampal synaptic plasticity and memory performance.
Culling, perhaps due to greater maternal milk availability, is able
to stimulate somatic growth and overcome synaptic and functional
abnormalities resulting from neonatal DEX treatment. Although
further investigations are needed to elucidate the molecular
mechanisms involved in the culling effects, our findings demon-
strate that supporting normal development and somatic growth
may exert beneficial effects to reduce lasting adverse effects of
neonatal DEX treatment on hippocampal function. These findings
are of clinical importance because it is now difficult to avoid the
use of corticosteroids in neonatology and perinatology to fight the
problems of chronic lung disease.
Materials and Methods
Animals
Pregnant Sprague-Dawley rats (250–280 gm body weight) were
housed in individual cages under the conditions of a 12 h light/
dark cycle (lights on from 07:00 to 19:00 h) and ad libitum access to
food and water. Pups were born on days 22–23 of gestation. On
the day of birth (designated day 0), the number of pups per litter
was culled to eight and four for Group A and B, respectively, with
equal numbers of both sexes. Pups were weaned at 21 days of age
and remained group housed with same-sex littermates until
experimentation at 5 weeks of age. Only male rats were used in
each experiment. All procedures were performed according to
NIH guidelines for animal research (Guide for the Care & Use of
Laboratory Animals, NRC, 1996) and were approved by the
Institutional Animal Care and Use Committee of National Cheng
Kung University (Approval No. 97225). All efforts were made to
minimize animal suffering and to use only the number of animals
necessary to produce reliable scientific data.
Dexamethasone treatment
Four treatment groups were assigned for each litter: SAL- and
DEX-treated pups from litters that had bee culled to 8 pups on P0;
and SAL- and DEX-treated pups from litters that had bee culled
to 4 pups on P0. All pups within each litter were removed from
their home cage and separated from their mother for injection and
body weight measurement (between 11:00 and 13:00 h) for a
period of 5 min. Pups in the DEX-treated group received a daily
intraperitoneal injection of DEX between P1 and P3. DEX was
given in tapering doses of 0.5 mg/kg on P1, 0.3 mg/kg on P2, and
0.1 mg/kg on P3 as described previously [8,9,10]. Animals in the
vehicle group received equivalent volumes of intraperitoneal
injection of sterile SAL as the pups in the DEX-treated group.
Electrophysiological, biochemical, immunohistochemical and
behavioral experiments were performed using different groups of
rats at the age of 5 weeks of age.
Maternal care characterization
Behavioral observations were performed with mothers and their
litters housed in 48622626 cm Plexiglas cages. Maternal care
behaviors were video recorded using a digital video camera for six
60-min observation periods daily for the first 10 days postpartum
and scoring was performed with the behavioral tracking system
Ethovision (Noldus, Wageningen, The Netherlands) as described
previously [19]. Pups were marked with nontoxic ink for
identification. Observations were performed at four periods during
the light phase (08:00, 11:00, 14:00 and 17:00 h) and two periods
during the dark phase of the light/dark cycle (20:00 and 06:00 h).
Within each observation period, the maternal behavior at a pup
was scored every 3 min (20 observations per period66 periods per
day =120 observations/pup/day). All observations were per-
formed by individuals unaware of the origin of the pups. The
following maternal behaviors were scored: (1) mother licking and
grooming the pup, (2) mother nursing the pup in an arched-back
Figure 8. Culling rescues neonatal DEX treatment-induced
impairment of memory retention for one-trial passive avoid-
ance task at 5 weeks old. (A) Retention performance in one-trial
passive avoidance task is expressed the latency time required for the
animal to enter the dark compartment. Summary bar graphs depicting
the latencies to enter the dark compartment on retention testing
session in 5-week-old rats neonatally treated with SAL or DEX for Group
A. (B) Summary bar graphs depicting the latencies to enter the dark
compartment on retention testing session in 5-week-old rats neonatally
treated with SAL or DEX for Group B. The total number of animals
examined is indicated by n in parenthesis. Data represent the mean 6
SEM. *p,0.05 compared with SAL-treated rats.
doi:10.1371/journal.pone.0012806.g008
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passive posture in which the mother lays over the pup and (5)
mother off the pup. The percentage of time spent in the maternal
contact was analyzed.
Hippocampal slice preparations and electrophysiology
Hippocampal slices (400 mm) were prepared from 5-week-old
rats using standard procedures as described previously [9], allowed
to recover for a minimum of 1 h, and then transferred to a
submersion-type recording chamber continually perfused oxygen-
ated artificial CSF (aCSF) solution (in mM: NaCl, 117; KCl, 4.7;
CaCl2, 2.5; MgCl2, 1.2; NaHCO3, 25; NaH2PO4, 1.2; glucose, 11)
at a flow rate of 2–3 ml/min at 32.060.5uC. Extracellular field
potential recordings were carried out using an Axoclamp-2B
amplifier (Axon Instruments, Union City, CA). Microelectrodes
were pulled from microfibre 1.0 mm capillary tubing on a Brown-
Flaming electrode puller (Sutter Instruments, San Rafael, CA).
The responses were low pass filtered at 2 kHz, digitally sampled at
5–10 kHz, and analyzed using pCLAMP software (Version 7.0;
Axon Instruments). Postsynaptic responses were evoked in CA1
stratum radiatum by stimulation of Schaffer collateral/commis-
sural afferents at 0.033 Hz with a bipolar stimulating electrode.
The stimulation strength was set to elicit response for which the
amplitude was 30–40% of the maximum spike-free response. Field
EPSPs were recorded with a glass pipette filled with 1 M NaCl (2–
3M V resistance) and the fEPSP slope was measured from
approximately 20–70% of the rising phase using a least-squares
regression. PPF ratio was assessed by using a succession of paired
pulses separated by intervals of 20, 40, 60, 80, 150, and 200 ms.
The LTP was induced by HFS, at the test pulse intensity,
consisting of two 1-sec trains of stimuli separated by an intertrain
interval of 20 sec at 100 Hz. The LTD was induced by LFS
delivered at 1 Hz for 15 min (900 pulses) or a brief bath
application of group I mGluR agonist DHPG (Tocris Cookson
Ltd., Bristol, UK) for 5 min.
Whole-cell recordings were made from hippocampal CA1
pyramidal cells by using a patch clamp amplifier (Axopatch 200B,
Axon Instruments) under infrared differential interference contrast
optics. Electrical signals were low-pass filtered at 2 kHz, digitized
at 10 kHz using a 12 bit analog-to-digital converter (Digidata
1320, Axon Instruments). An Intel Pentium-based computer with
pCLAMP software (Version 8.0; Axon Instruments) and Mini
Analysis 4.3 (Synaptosoft, Leonia, NJ) were used for on-line
acquisition and off-line analysis of the data. For measurements of
synaptically evoked IPSCs, a bipolar stainless steel stimulating
electrode was placed in CA1 stratum radiatum to stimulate the
Schaffer collateral/commissural afferents at 0.05 Hz and neurons
were voltage-clamped at 270 mV in the presence of CNQX
(20 mM) and D-APV (50 mM). Patch pipettes were pulled from
borosilicate capillary tubing and heat polished. The electrode
resistance was typically 3–6 MV. The composition of intracellular
solution was (mM): CsCl, 150; HEPES, 10; MgCl2, 2; EGTA, 0.5;
Na2ATP, 3; Na3GTP, 0.3 and sucrose to bring osmolarity to 290–
295 mOsM and pH to 7.3. Miniature IPSCs were recorded at a
holding potential of 270 mV in the presence of tetrodotoxin
(TTX, 1 mM), CNQX (20 mM) and D-APV (50 mM). Detection
threshold of 5 pA was used for mIPSCs. N-(2,6-dimethylpheny-
l)acetamide-2-triethylammonium bromide (QX-314, 5 mM) was
included in the intracellular solution for IPSC and mIPSC
recordings. For assessments of neuronal excitability, the whole-
cell current-clamp was used to record spikes evoked by injection of
depolarizing current pulses (0.2 nA, 500 ms) and CsCl in the
intracellular solution was replaced with KCl. Series resistance and
input resistance were monitored on-line throughout the recordings
and data were discarded if resistance changed by more than 20%.
The experiments were performed with the experimenter blind to
the status of the animals from which slices were prepared.
Passive avoidance training and testing
A one-way passive avoidance learning task was selected as the
tool for behavioral assessment to measure associative memory
retention performance in rats from each group as described
previously [9]. Passive avoidance consisted of a training trial on
the first day and a retention test 24 h later. On the training day,
each rat was placed individually into the lit compartment of an
automated passive avoidance system (Ugo Basile, Comerio, Italy)
and, after entering the dark compartment, was given a scrambled
foot shock (0.5 mA for 2 sec). Rats were tested for memory
retention at 24 h after training. In the test section the foot shock
was omitted; i.e., the conditioned stimulus (the apparatus) was not
followed by unconditioned stimulus (electric shock). The latency to
enter the dark compartment was scored. If a rat did not enter the
chamber in 300 sec, the trial was terminated.
Novel object recognition assay
The novel object recognition and memory retention test was
used to examine recognition memory. The test apparatus
consisted of a square chamber with ground area measuring
40640 cm and object recognition test was conducted with
dimmed light (approximately 10 Lux). The objects to be
discriminated were a glass marble and a plastic dice. Before
training, rats were habituated to the experimental arena by
allowing them to freely explore it 10 min per day for 2
consecutive days in the absence of stimulus objects, and then
returned to their home cages. In the training session, each rat
was introduced for 5 min in the arena containing two identical
objects (marble or dice). Locomotor activity and the duration for
t h er a ts p e n ti ne x p l o r i n gt h eo b j e c t sw e r ev i d e or e c o r d e du s i n g
a digital video camera and scoring was performed with the
behavioral tracking system Ethovision (Noldus, The Nether-
lands). Exploration was defined as sniffing or touching the
stimulus object with the nose or forepaws. Sitting on or turning
around the objects was not considered exploratory behavior.
Twenty-four hours after training, rats were tested by reintro-
ducing them in the arena for 5 min. One of the objects was
familiar (presented during the training session) and the other
was novel (never presented before). The amount of time spent
exploring each object was recorded by an observer blind to the
treatment. A discrimination index was calculated to determine
preference of rats for exploration of the novel object relative to
the familiar object in the test session. This index was calculated
for each rat as proportion increase above the time each rat spent
exploring the familiar object using the following formula: [(time
exploring novel object 2 time exploring familiar object)/(time
spend exploring familiar object + time spent exploring novel
object)] 6100%.
Preparation of postsynaptic density fractions
Isolation of PSD was performed according to the procedure of
Wells et al [41]. Briefly, the microdissected CA1 regions were
homogenized in ice-cold Ca
2+,M g
2+-free buffer (50 mM HEPES,
100 mM NaCl, and 3 mM K acetate, pH 7.4) with RNase
inhibitor (15 U/ml) and was centrifuged at 20006 g for 1 min.
Supernatants were passed through two 100 mm nylon mesh filters,
followed by a 5 mm pore filter. The filtrate was then centrifuged at
10006g for 10 min and then was gently resuspended with same
buffer at a protein concentration of 2 mg/ml.
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For each experimental group, homogenates from at least three
slices were pooled. The microdissected subregions were lysed in
ice-cold Tris-HCl buffer solution (TBS; pH 7.4) containing a
cocktail of protein phosphatase and proteinase inhibitors (50 mM
Tris-HCl, 100 mM NaCl, 15 mM sodium pyrophosphate, 50 mM
sodium fluoride, 1 mM sodium orthovanadate, 5 mM EGTA,
5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM
microcystin-LR, 1 mM okadaic acid, 0.5% Triton X-100, 2 mM
benzamidine, 60 mg/ml aprotinin, and 60 mg/ml leupeptin) to
avoid dephosphorylation and degradation of proteins, and ground
with a pellet pestle (Kontes glassware, Vineland, NJ, USA).
Samples were sonicated and spun down at 15,0006 ga t4 uCfor
10 min. The supernatant was then assayed for total protein
concentration using Bio-Rad Bradford Protein Assay Kit (Hercu-
les, CA). Each sample from tissue homogenate or PSD protein was
separated in 10% SDS-PAGE gel. Following the transfer on
nitrocellulose membranes, blots were blocked in buffer solution
containing 5% milk and 0.1% Tween-20 in PBS (124 mM NaCl,
4 mM KCl, 10 mM Na2HPO4, and 10 mM KH2PO4, pH 7.2)
for 1 h and then blotted for 2 h at room temperature with the
monoclonal antibodies that recognizes phosphorylated CaMKIIa
at threonine-286 site (1:2000; Affinity Bioreagents, Golden, CO)
or PP1 (1:1000; Upstate Biotechnology, Lake Placid, NY, USA). It
was then probed with HRP-conjugated secondary antibody for 1 h
and developed using the ECL immunoblotting detection system
(Amersham Biosciences, Buckinghamshire, UK), according to
manufacturer’s instructions. The immunoblots using phosphory-
lation site-specific antibodies were subsequently stripped and
reprobed with an antibody that recognizes CaMKIIa (1:1000;
Affinity Bioreagents). The relative amount of CaMKIIa phos-
phorylation was analyzed by determining the ratio of the signals
detected by using the phosphorylation site-specific antibody and
the phosphorylation-independent antibody. Immunoblots were
analyzed by densitometry using Bio-profil BioLight PC software.
Only film exposures in the linear range of the ECL reaction were
used for quantification analysis. Background correction values
were subtracted from each lane to minimize variability across
membranes.
Histology and immunohistochemistry
Animals were deeply anesthetized with sodium pentobarbital
(100 mg/kg, intraperitoneally) and perfused transcardially with
0.1 M PBS and 4% paraformaldehyde. After the perfusion, brains
were removed and continue to fix in 4% paraformaldehyde for
48 h at 4uC and then transferred to the solution containing 30%
sucrose that immersed in 4uC for at least 48 h before slicing.
Coronal hippocampal slices (25 mm) were collected, washed with
0.3% Triton X-100, and then incubated for blocking with solution
containing 3% goat serum in PBS. For quantitative evaluation of
neuronal numbers with Nissl staining, sections were mounted
directly on gelatin-coated glass slides and dried. The slides were
stained with 1.0% cresyl violet, dehydrated through a series of
ethanol, cleared, and coverslipped with permount (Fisher
Scientific, Electron Microscopy Sciences, Washington, PA). For
immunohistochemistry, the free-floating sections were washed
with TBS-T wash buffer (10 mM Tris-HCl, 150 mM NaCl and
0.025% Tween 20; pH 7.4) and incubated with 1% H2O2 for
30 min to block endogenous peroxidase, and rinsed in PBS. The
sections were incubated overnight at 4uC with a parvalbumin
antibody (1:1000; Millipore Bioscience Research Reagents,
Temecula, CA) in PBS with 0.1% Triton X-100. Sections were
then incubated with biotinylated secondary antibody (1:200;
Vector Laboratories, Burlingame, CA) for 90 min, followed by
incubation with avidin and biotinylated peroxidase complex
(Vector Laboratories). The immunostained sections were mounted
on gelatin-subbed glass slides, dried, dehydrated, cleared, and
coverslipped with permount. Specific staining was abolished by
omission of primary antibody.
Image acquisition and quantification
Nissl staining and parvalbumin immunostaining within hippo-
campal CA1 region were quantified in images from about 2.5 to
4.5 mm posterior to Bregma every sixth coronal section captured
at 2006 magnification and digitized with an Olympus BX51
microscope coupled to an Olympus DP70 digital camera
(Olympus, Tokyo, Japan). Then, all images were imported into
NIH ImageJ software for analysis. The number of interneurons
labeled for parvalbumin in stratum origin and pyramidale of the
CA1 region in neonatal saline- or dexamethasone-treated rats was
estimated by using the optical fractionator-sampling method
[42,43]. A total of 4 counting frames (2006200 mm square) were
sampled per CA1 region in each section. Neurons were counted
only when the nucleus was in clear focus within the counting
frame. The parvalbumin-immunoreactive cells in hippocampal
CA1 region were classified into two distinct subpopulations: multi-
polar round cells with a long axis: short axis ratio ,1.5 and larger
spindle-shaped cells with a long axis: short axis ratio $1.5 [44]. All
counting was performed in a blind manner.
Drugs
DHPG, CNQX, D-APV and TTX were purchased from Tocris
Cookson (Bristol, UK); DEX was obtained from Sigma (St Louis,
MO).
Data analysis
All data are expressed as means 6 SEM. Data of body weight,
maternal care, stimulus-response curve of fEPSPs or IPSCs, PPF
ratio, the average frequency or amplitude of mIPSCs, novel object
recognition task and passive avoidance memory retention test were
analyzed by one-way analysis of variance (ANOVA), followed by
Fisher’s least significance difference test when appropriate. For
LTP and LTD experiments, statistical analysis was performed
using the Mann-Whitney U-test. Western blot data were analyzed
using unpaired Student’s t-test. Number of animals used is
indicated by n. Probability values of p,0.05 were considered to
represent significant differences.
Supporting Information
Figure S1 Effect of neonatal DEX treatment on the number of
pyramidal neurons in hippocampal CA1 region. (A) Representa-
tive photographs with Cresyl violet staining of CA1 region
showing that the number of pyramidal neurons was not
significantly affected by neonatal DEX treatment compared with
age-matched SAL-treated rats. (B) Group data showing the
summary results from 4 rats of each group at 5 weeks of age.
Found at: doi:10.1371/journal.pone.0012806.s001 (6.81 MB TIF)
Figure S2 Effect of neonatal DEX treatment on hippocampal
CA1 neuronal excitability. Top, representative traces of action
potential firing elicited by a constant depolarizing current injection
(0.2 nA, 500 ms) in hippocampal CA1 pyramidal neurons from 5-
week-old rats neonatally treated with SAL or DEX for Group A
and Group B. The neurons were held at -70 mV in current-clamp
mode. Bottom, summary of the number of action potentials by
constant depolarizing current injection in slices from rats
neonatally treated with SAL or DEX for Group A and Group
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PLoS ONE | www.plosone.org 11 September 2010 | Volume 5 | Issue 9 | e12806B. The total number of animals examined is indicated by n in
parenthesis.
Found at: doi:10.1371/journal.pone.0012806.s002 (1.32 MB TIF)
Figure S3 Effect of neonatal DEX treatment on the number of
parvalbumin (PA)-immunoreactive interneurons in the hippocam-
pal CA1 region. (A) Representative photomicrographs with PV-
immunostaining of CA1 region showing that the expression of PV-
immunoreactive interneurons was not altered by neonatal DEX
treatment in rats from Group A and Group B. (B) Group data
showing the summary results from 6 rats of each group at 5 weeks
old. The parvalbumin-immunoreactive cells in hippocampal CA1
region were classified into two distinct subpopulations: multi-polar
round cells with a long axis: short axis ratio ,1.5 and larger
spindle-shaped cells with a long axis: short axis ratio . or =
1.5.(n=4 for each group).
Found at: doi:10.1371/journal.pone.0012806.s003 (7.68 MB TIF)
Figure S4 Effect of neonatal DEX treatment on GABAA
receptor-mediated inhibition of hippocampal CA1 pyramidal
neurons. (A) Stimulus-response curve of IPSC amplitude versus
stimulus intensity in the CA1 region of hippocampal slices from 5-
week-old rats of Group A that received neonatal SAL or DEX
treatment. Inset shows overlaid traces (each an average of 3
responses) evoked in a slice from a SAL- (left set of traces) and
DEX-treated (right set of traces) rats. Monosynaptic IPSCs were
evoked while holding neurons in voltage-clamp at -70 mV in the
presence of CNQX (20 microM) and D-APV (50 microM). (B)
Stimulus-response curve of IPSC amplitude versus stimulus
intensity in the CA1 region of hippocampal slices from 5-week-
old rats of Group B that received neonatal SAL or DEX
treatment. (C) Representative traces and summary bar graph
depicting the frequency and amplitude of mIPSCs of hippocampal
CA1 pyramidal neurons from 5-week-old rats neonatally treated
with SAL or DEX for Group A. Miniature IPSCs were recorded
while holding neurons in voltage-clamp at -70 mV in the presence
of CNQX (20 microM) and D-APV (50 microM). (D) Represen-
tative traces and summary bar graph depicting the frequency and
amplitude of mIPSCs of hippocampal CA1 pyramidal neurons
from 5-week-old rats neonatally treated with SAL or DEX for
Group B. The total number of animals examined is indicated by n
in parenthesis.
Found at: doi:10.1371/journal.pone.0012806.s004 (2.29 MB TIF)
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